| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |